MaxInsights has raised $30.0M in seed funding, with Peak XV Partners, Tola Capital, South Park Commons, INCE Capital and Alumni Ventures participating.
The company makes web-based software that helps small and mid-sized medical device and drug developers work out how their products will be reimbursed in different European markets, where rules vary country by country and can shift with political and cost pressures. MaxInsights says its system walks users through a set of questions and returns tailored guidance, with deeper layers available depending on the product, market and available findings.
